1 Min Read
Dec 14 (Reuters) - Cspc Pharmaceutical Group Ltd
* Cspc Zhongqi agrees to grant right to teva to perform necessary non-clinical and clinical studies and apply for relevant approvals
* Unit entered into an agreement with Teva Pharmaceuticals Usa, Inc.
* Pursuant to agreement, Cspc Zhongqi is responsible for pre-clinical development of product
* Teva will make milestone payments to Cspc Zhongqi of up to an aggregate amount of us$100 million subject to product's application progress Source text for Eikon: Further company coverage: